Stay updated on ARO-RAGE in Healthy Subjects Clinical Trial

Sign up to get notified when there's something new on the ARO-RAGE in Healthy Subjects Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ARO-RAGE in Healthy Subjects Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The ClinicalTrials.gov page footer now displays site revision v3.8.1 instead of v3.8.0.
    Difference
    0.1%
    Check dated 2026-11-22T02:08:48.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    The record presents details of Arrowhead Pharmaceuticals’ completed Phase 1 ARO-RAGE study in healthy volunteers, including its eligibility criteria, study design, interventions, and safety and pharmacokinetic outcomes.
    Difference
    41%
    Check dated 2026-11-08T04:30:15.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    The footer's site revision identifier changed from v3.7.2 to v3.8.0. The page still displays a 403 Forbidden error instead of the study record.
    Difference
    0.2%
    Check dated 2026-11-01T01:34:12.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    A banner announces NIH website updates and says that some federal agencies are using “Super Intelligence” instead of “Artificial Intelligence” during a transition.
    Difference
    1%
    Check dated 2026-10-25T01:30:17.000Z thumbnail image
  6. Check
    36 days ago
    Change Detected
    Summary
    The footer site revision changed from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-18T01:11:03.000Z thumbnail image
  7. Check
    43 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov error page’s footer revision changes from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-11T01:46:44.000Z thumbnail image

Stay in the know with updates to ARO-RAGE in Healthy Subjects Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ARO-RAGE in Healthy Subjects Clinical Trial page.